Panel: Designing Trials with Access in Mind

Session details:

Exploring how early payer input and evidence generation strategy are reshaping Phase 3 development 

·       Discover ways to embed payer needs in Phase 3 study design 

·       Examine strategies for choosing endpoints that reflect value and differentiation 

·       Assess the benefits of bridging the expectations of regulators and payers